NORDIC BIOTECH HOLDING ApS
CVR 26409683 · Private limited company (ApS) · Active · Medium risk
NORDIC BIOTECH HOLDING ApS is a Private limited company (ApS), founded on , based in Hørsholm. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 1.4% over the next 12 months, which is 1.0 times the average for Danish companies. 20 annual reports have been published, of which 5 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 139k and a net result of DKK -7,860. CEO: Torsten Bjørn.
Bankruptcy risk for NORDIC BIOTECH HOLDING ApS
1.0 × the average (1.41%) · higher risk than 77% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 26409683
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (24 years)
- Address
- Slotsmarken 12, 1. th
2970 Hørsholm - Municipality
- Hørsholm
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 125k
- Employees
- 1 (2012)
- Auditor
- Grant Thornton, Godkendt Revisionspartnerselskab
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 5 of 24 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 25.6% |
| Current ratio | 11% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 3 |
| CEO's previous bankruptcies | 1 |
| Other companies at the address | 58 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -40k | DKK -41k | DKK -627k |
| Net profit | DKK -7,860 | DKK -39k | DKK -515k |
| Equity | DKK 139k | DKK 147k | DKK 578k |
| Total assets | DKK 545k | DKK 507k | DKK 1.0m |
| Cash | DKK 1,415 | DKK 0 | – |
| Short-term debt | DKK 406k | DKK 360k | – |
| Avg. employees | 0 | 0 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Grant Thornton, Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 166 | ||
| 1 Jan 2024 – 31 Dec 2024 | 178 | ||
| 1 Jan 2023 – 31 Dec 2023 | 180 | ||
| 1 Jan 2022 – 31 Dec 2022 | 175 | ||
| 1 Jan 2021 – 31 Dec 2021 | 200 | Late | |
| 1 Jan 2020 – 31 Dec 2020 | 197 | Late | |
| 1 Jan 2019 – 31 Dec 2019 | 407 | Late | |
| 1 Jan 2018 – 31 Dec 2018 | 163 | ||
| 1 Jan 2017 – 31 Dec 2017 | 213 | Late | |
| 1 Jan 2016 – 31 Dec 2016 | 151 | ||
| 1 Jan 2015 – 31 Dec 2015 | 167 | ||
| 1 Jan 2014 – 31 Dec 2014 | 155 | ||
| 1 Jan 2013 – 31 Dec 2013 | 163 | ||
| 1 Jan 2012 – 31 Dec 2012 | 168 | ||
| 1 Jan 2011 – 31 Dec 2011 | 157 | ||
| 1 Jan 2010 – 31 Dec 2010 | 174 | ||
| 1 Jan 2009 – 31 Dec 2009 | 173 | ||
| 1 Jan 2008 – 31 Dec 2008 | 168 | ||
| 1 Jan 2007 – 31 Dec 2007 | 172 | ||
| 1 Jan 2006 – 31 Dec 2006 | 191 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Torsten Bjørn | Current | |
| CEO | Sigbjørn Georg Nielsen Kjærgård | ||
| CEO | Sigbjørn Georg Nielsen Kjærgård | ||
| Owner (100%) | FINANSMANAGEMENT ApS | Current | |
| Owner (100%) | Sigbjørn Georg Nielsen Kjærgård | ||
| Auditor | LOKAL REVISORERNE ApS | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Auditor | DANSK REVISION MARIAGERFJORD, STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | Sigbjørn Georg Nielsen Kjærgård | Current |
The CEOs' other companies
Torsten Bjørn – 21 other companies, of which 2 bankrupt
- NATURAL MEDICO TECH ApS Bankrupt 26 Nov 2010
- VICH 3955 ApS Bankrupt 17 Oct 1996
- AKI Therapeutics A/S Active
- AQUA-WALL DANMARK A/S Fusioneret
- BIOPORTO DIAGNOSTICS A/S Active
- DKA CONSULT ApS Opløst
- DKA EJENDOMME ApS Opløst
- Geysir Holding ApS Active
- Geysir Invest ApS Active
- Nordic Pharma Lab ApS Active
- Nordic Science Group ApS Active
- REPOCEUTICALS A/S Active
- REPONEX PHARMACEUTICALS A/S Active
- REPOS PHARMA ApS Opløst
- SAX FINANS ApS Active
- SCHWANEBECK VERWALTUNG ZWEI ApS Opløst
- SPONSOR SUPPORT ApS Compulsorily dissolved
- SPRINGE/GESTORF VERWALTUNG ApS Active
- Serenova A/S Opløst
- VICTOR & FABIAN ApS Compulsorily dissolved
- VULKAN INVEST ApS Active
Sigbjørn Georg Nielsen Kjærgård – 8 other companies, of which 1 bankrupt
- Science Academy ApS Bankrupt 14 May 2024
- ACTION PHARMA HOLDING I A/S Opløst
- AKI Therapeutics A/S Active
- GYNZONE ApS Active
- REPOCEUTICALS A/S Active
- REPONEX PHARMACEUTICALS A/S Active
- SELSKABET AF 20.02.2002 ApS Opløst
- SYNACT PHARMA ApS Active
Address history (2 moves)
| Slotsmarken 12, 1. th, 2970 Hørsholm | |
| Sandgravvej 6, st. tv, 8000 Aarhus C | |
| Degnebakken 31, 8230 Åbyhøj |
Former names
| NORDIC BIOTECH HOLDING ApS | – now |
| SN BIOTECH HOLDING ApS | – |
Employees per year
Other companies at the same address
- CVIP ApS Bankrupt
- CVIP HOLDING ApS Bankrupt
- HI AF 26/11-2010 A/S Bankrupt
- Liquid Wind Denmark ApS Bankrupt
- A/S CRYSTINOL Fusioneret
- AKI Therapeutics A/S Active
- ApS KBUS 17 NR. 4807 Opløst
- ApS KBUS 38 NR. 1027 Opløst
- Aurea Kapital ApS Active
- BIOPHARMA HOLDING ApS Opløst
- BLANKAMI ApS Opløst
- CAMBRIDGE TECHNOLOGY PARTNERS A/S Opløst
- DKA ADMINISTRATION ApS Opløst
- DKA CONSULT ApS Opløst
- DKA EJENDOMME ApS Opløst
- DKA FINANS ApS Opløst
- DKA INVEST ApS Opløst
- EXPANDIT DEVELOPMENT ApS Active
- EXPANDIT HOLDING A/S Active
- EXPANDIT INTERNATIONAL A/S Active
- EXPANDIT MOBILE ApS Active
- EXPANDIT UTILITIES ApS Opløst
- Erestas ApS Active
- FACET 4 ApS Compulsorily dissolved
- FINANSMANAGEMENT 2 ApS Opløst
Similar companies in Hørsholm
- Gubra Beta ApS Hørsholm
- Gubra Alpha ApS Hørsholm
- FreeOfStrain ApS Hørsholm
- Curanthia Holdings ApS Rungsted Kyst
- Afyx Development A/S Hørsholm
- CHRETO ApS Hørsholm
- Gubra A/S Hørsholm
- ParaTech ApS Rungsted Kyst
- PLUMBAGO IVS Rungsted Kyst
- POLYPLEX IVS Rungsted Kyst
- 7TM A/S Hørsholm
Questions and answers about NORDIC BIOTECH HOLDING ApS
Has NORDIC BIOTECH HOLDING ApS gone bankrupt?
No, NORDIC BIOTECH HOLDING ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of NORDIC BIOTECH HOLDING ApS?
Our model estimates a bankruptcy risk of 1.4% over the next 12 months (medium risk), which is 1.0 times the average for Danish companies.
Who is the CEO of NORDIC BIOTECH HOLDING ApS?
Torsten Bjørn is the CEO of NORDIC BIOTECH HOLDING ApS.
Who is the auditor of NORDIC BIOTECH HOLDING ApS?
NORDIC BIOTECH HOLDING ApS most recently used Grant Thornton, Godkendt Revisionspartnerselskab.
When was NORDIC BIOTECH HOLDING ApS founded?
NORDIC BIOTECH HOLDING ApS was founded on 21 December 2001.
What is the equity of NORDIC BIOTECH HOLDING ApS?
Equity was DKK 139k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.